Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Walters, A. Cockroft, T. Griffiths, K. Rocchiccioli, B. Davies (1981)
Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels.Thorax, 36
S. Bateman, J. Pidgeon, S. Spiro, A. Johnson (1978)
The metabolic effects of inhaled salbutamol.British journal of clinical pharmacology, 5 2
O. Holland, J. Nixon, L. Kuhnert (1981)
Diuretic-induced ventricular ectopic activity.The American journal of medicine, 70 4
N. O'Mullane (1979)
High-carbohydrate diets and insulin-dependent diabetics.British Medical Journal, 2
Kendall (1982)
Cardiovascular and metabolic effects of terbutaline.J. clin. hosp. Pharm., 7
Martin Kendall, S. Dean, D. Bradley, R. Gibson, D. Worthington (1982)
CARDIOVASCULAR AND METABOLIC EFFECTS OF TERBUTALINEJournal of Clinical Pharmacy and Therapeutics, 7
E. Neville, P. Corris, J. Vivian, S. Nariman, G. Gibson (1982)
Nebulised salbutamol and angina.British Medical Journal (Clinical research ed.), 285
S. Williams, S. Winner, T. Clark (1981)
Comparison of inhaled and intravenous terbutaline in acute severe asthma.Thorax, 36
B. Simonsson, H. Svedenblad, I. Axelsson, A. Andersson (1974)
Systemic effects of inhalation of terbutaline with IPPB in normal subjects.Scandinavian journal of respiratory diseases, 55 1
S. Smith, M. Kendall (1983)
INHALED BRONCHODILATORS AND HYPOKALAEMIAThe Lancet, 322
A. Neville, J. Palmer, J. Gaddie, C. May, K. Palmer, L. Murchison (1977)
Metabolic effects of salbutamol: comparison of aerosol and intravenous administration.British Medical Journal, 1
When conventional therapeutic doses of nebulised salbutamol were given to normal volunteers, there was a significant rise in pulse rate, systolic blood pressure and plasma glucose and a significant fall in diastolic blood pressure and serum potassium in comparison with placebo. Such changes may be potentially hazardous in certain situations. Patients with airways obstruction due to chronic bronchitis who have coexistent ischaemic heart disease or diuretic induced hypokalaemia may be at particular risk from the unwanted cardiovascular and biochemical responses to nebulised salbutamol.
British Journal of Clinical Pharmacology – Wiley
Published: Oct 1, 1984
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.